OVERVIEW

Gestational Diabetes: Continued Controversies is organized by Baptist Health South Florida and will be held from Feb 01, 2019 - Feb 01, 2022.

Accreditation:
• 1.00 AMA PRA Category 1 Credit™
• 1.00 Nurse Practitioners
• 1.00 General certificate of attendance

Target Audience:
Obstetricians, Gynecologists, General Surgeons, General Practitioners, Family Physicians, Pediatricians, Oncologists, Physician Assistants, Nurse Practitioners, Nurse Midwives and all other interested healthcare professionals.

Description:
Gestational diabetes mellitus (GDM) affects approximately 300,000 women annually. The proposed International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria would increase this number significantly. Mark B. Landon, M.D., discusses appropriate fetal surveillance in GDM patients and how to integrate the use of dietary therapy, exercise, the indications for insulin and oral hypoglycemic agents and strategies for monitoring maternal glucose control.

Objectives:
• Describe the metabolic changes in pregnancy that produce a “diabetogenic stress” and insulin resistance.
• Identify the short- and long-term morbidities for the woman with GDM and her infant.
• Construct an algorithm to detect GDM using methods currently recommended for screening and diagnosis.
• Integrate the use of dietary therapy, exercise, the indications for insulin and oral hypoglycemic agents and strategies for monitoring maternal glucose control.

Additional details will be posted as soon as they are available.

 

Credits
  • 1 CME
  • SPECIALITIES

    Endocrinology, Metabolism and Diabetes

    RELATED ONLINE COURSES

    By Medical Education Systems...

    Nov 28, 2025 - Nov 28, 2026 | Webcast

    Respiratory Therapists
    1 CEUs
    More actions

    Dec 21, 2024 - Dec 01, 2026 | Text-Based CME

    Endocrinology Nurse
    1 Contact Hours
    More actions
    By Medical Education Systems...

    Aug 04, 2025 - Aug 04, 2026 | Text-Based CME

    Endocrinology, Metabolism and Diabetes
    15 CEUs
    ...
    More actions
    US$74.99